WHO and Pew Call for Acceleration of Antibiotic Development

Assessments from both organizations find that urgent action is needed to address growing resistance threat

WHO and Pew Call for Acceleration of Antibiotic Development

As part of their ongoing collaboration to combat antibiotic-resistant bacteria, the World Health Organization and The Pew Charitable Trusts are urging policymakers, pharmaceutical companies, research funders, and other stakeholders to act swiftly to reinvigorate the stagnant antibiotic pipeline. The call to action follows analyses from each organization earlier this year showing that there are far too few antibiotics in clinical development.

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.